Literature DB >> 6170723

Relation of interferon production to the limited replication of Newcastle disease virus in L cells.

Y Nagai, Y Ito, M Hamaguchi, T Yoshida, T Matsumoto.   

Abstract

Growth of Newcastle disease virus (NDV) in L cells, where the virus undergoes limited replication, has been compared to that in fully permissive BHK-21 host cells. The synthesis of viral proteins and the production of infectious progeny were found to occur normally at early times of infection in L cells. However, the subsequent amplification of viral protein synthesis did not take place and instead of infectious virions, non-infectious haemagglutinin was the predominant product. This shift of replication pattern from complete to incomplete virus production seemed to be temporally related to the appearance and accumulation of interferon (IFN) in the system. The addition of specific antiserum against mouse IFN to the infected L cell cultures was able to circumvent such restriction of virus growth. In the presence of the antiserum, synthesis of viral proteins was found to progress normally, with the production of a high amount of infectious progeny comparable to that of the permissive system. These results suggest that the limited replication of NDV in L cells may be due to interference by the endogenously produced IFN during the course of infection.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6170723     DOI: 10.1099/0022-1317-55-1-109

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  13 in total

1.  Relationship between within-host fitness and virulence in the vesicular stomatitis virus: correlation with partial decoupling.

Authors:  Victoria Furió; Raquel Garijo; María Durán; Andrés Moya; John C Bell; Rafael Sanjuán
Journal:  J Virol       Date:  2012-09-05       Impact factor: 5.103

2.  Isolation of highly fusogenic variants of simian virus 5 from persistently infected cells that produce and respond to interferon.

Authors:  D F Young; L Didcock; R E Randall
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

3.  Identification of Natural Molecular Determinants of Ross River Virus Type I Interferon Modulation.

Authors:  Adam Taylor; Suresh Mahalingam; Xiang Liu; Margit Mutso; Liubov Cherkashchenko; Eva Zusinaite; Lara J Herrero; Stephen L Doggett; John Haniotis; Andres Merits; Belinda L Herring
Journal:  J Virol       Date:  2020-03-31       Impact factor: 5.103

4.  Growth restriction of negative-strand-RNA viruses in a rat 3Y1 cell line.

Authors:  H Saso; K Shimokata; T Toyoda; B Gotoh; Y Nagai
Journal:  Med Microbiol Immunol       Date:  1990       Impact factor: 3.402

5.  Isolation and characterization of mouse FM3A cell mutants which are devoid of Newcastle disease virus receptors.

Authors:  T Hara; S Hattori; M Kawakita
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

6.  West nile virus infections suppress early viral RNA synthesis and avoid inducing the cell stress granule response.

Authors:  S C Courtney; S V Scherbik; B M Stockman; M A Brinton
Journal:  J Virol       Date:  2012-01-18       Impact factor: 5.103

7.  Identification of thieno[3,2-b]pyrrole derivatives as novel small molecule inhibitors of neurotropic alphaviruses.

Authors:  Weiping Peng; Daniel C Peltier; Martha J Larsen; Paul D Kirchhoff; Scott D Larsen; Richard R Neubig; David J Miller
Journal:  J Infect Dis       Date:  2009-04-01       Impact factor: 5.226

8.  Fusion regulation proteins on the cell surface: isolation and characterization of monoclonal antibodies which enhance giant polykaryocyte formation in Newcastle disease virus-infected cell lines of human origin.

Authors:  Y Ito; H Komada; S Kusagawa; M Tsurudome; H Matsumura; M Kawano; H Ohta; M Nishio
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

9.  Replication of mumps virus in murine cells.

Authors:  M Tsurudome; A Yamada; M Hishiyama; Y Ito
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

10.  A mastoparan-derived peptide has broad-spectrum antiviral activity against enveloped viruses.

Authors:  Christopher J Sample; Kathryn E Hudak; Brice E Barefoot; Matthew D Koci; Moses S Wanyonyi; Soman Abraham; Herman F Staats; Elizabeth A Ramsburg
Journal:  Peptides       Date:  2013-07-26       Impact factor: 3.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.